Publications for Johan Rosell
Co-author map based on ISI articles 2007-

Publications mentioned in social media 41 times*

Keywords

urinary tumour trial treatment tamoxifen t1 survival stage risk recurrence radiotherapy prostate progression population-based patients median death carcinoma cancer bladder

Journal Articles

Vera Loorents, Johan Rosell, Charlott Karlsson, Maria Lidback, Kristina Hultman and Sussanne Börjeson
  Prophylactic training for the prevention of radiotherapy-induced trismus - a randomised study
  Acta Oncologica, 2014, 53(4), 530-538.
   Fulltext  PDF  

Georg Jancke, Johan Rosell and Staffan Jahnson
  Impact of surgical experience on recurrence and progression after TUR-BT in non-muscle-invasive bladder cancer
  SCANDINAVIAN JOURNAL OF UROLOGY, 2014, 48(3), 276-283.

Rune Sjödahl, Johan Rosell and Hans Starkhammar
  Causes of death after surgery for colon cancer-impact of other diseases, urgent admittance, and gender
  Scandinavian Journal of Gastroenterology, 2013, 48(10), 1160-1165.

Hans Olsson, Peter Söderkvist, Per Hultman, Johan Rosell and Staffan Jahnson
  MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
  BMC Urology, 2013, 13(5), .
   Fulltext  PDF  
 Web of Science® Times Cited: 4

Hans Olsson, Per Hultman, Johan Rosell and Staffan Jahnson
  Population-based study on prognostic factors for recurrence and progression in primary stage T1 bladder tumours
  Scandinavian Journal of Urology and Nephrology, 2013, 47(3), 188-195.

Johan Rosell, Bo Nordenskjöld, Nils-Olof Bengtsson, Tommy Fornander, Thomas Hatschek, Henrik Lindman, Per-Olof Malmstrom, Arne Wallgren, Olle Stål and John Carstensen
  Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-up
 
Altmetric usage: 2

  Breast Cancer Research and Treatment, 2013, 138(2), 467-473.
 Web of Science® Times Cited: 1

Annika Malmström, Roger Stupp, Monika Hegi, Johan Rosell and Roger Henriksson
  Treatment options in elderly patients with glioblastoma - Authors' reply
  The Lancet Oncology, 2012, 13(11), E461-E462.

Georg Jancke, Johan Rosell and Staffan Jahnson
  Residual tumour in the marginal resection after a complete transurethral resection is associated with local recurrence in Ta/T1 urinary bladder cancer
  Scandinavian Journal of Urology and Nephrology, 2012, 46(5), 343-347.
 Web of Science® Times Cited: 4

Annika Malmström, Bjorn Henning Gronberg, Christine Marosi, Roger Stupp, Didier Frappaz, Henrik Schultz, Ufuk Abacioglu, Bjorn Tavelin, Benoit Lhermitte, Monika E Hegi, Johan Rosell and Roger Henriksson
  Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
 
Altmetric usage: 10

  The Lancet Oncology, 2012, 13(9), 916-926.
 Web of Science® Times Cited: 105

Georg Jancke, Johan Rosell, Gunilla Chebil and Staffan Jahnson
  Bladder Wash Cytology at Diagnosis of Ta-T1 Bladder Cancer Is Predictive for Recurrence and Progression
  Urology, 2012, 80(3), 625-631.
 Web of Science® Times Cited: 1

Yang-mei Shen, Gunnar Arbman, Per Sandström, Per Gullstrand, Yu-Quan Wei, Hong Zhang, Johan Rosell, Birgit Olsson, Feng Peng, Han-Shuo Yang, Chun-Ting Wang and Xiao-Feng Sun
  Novel gene hBiot2 is an independent prognostic factor in colorectal cancer patients
  Oncology Reports, 2012, 27(2), 376-382.
 Web of Science® Times Cited: 2

Hans Olsson, Per Hultman, Nastaran Monsef, Johan Rosell and Staffan Johanson
  Immunohistochemical Evaluation of Cell Cycle Regulators: Impact on Predicting Prognosis in Stage T1 Urinary Bladder Cancer
  ISRN Urology, 2012, 2012, .
   Fulltext  PDF  

Georg Jancke, Johan Rosell and Staffan Jahnson
  Impact of tumour size on recurrence and progression in Ta/T1 carcinoma of the urinary bladder
  Scandinavian Journal of Urology and Nephrology, 2011, 45(6), 388-392.
 Web of Science® Times Cited: 3

Laszlo Tabar, Bedrich Vitak, Tony Hsiu-Hsi Chen, Amy Ming-Fang Yen, Anders Cohen, Tibor Tot, Sherry Yueh-Hsia Chiu, Sam Li-Sheng Chen, Jean Ching-Yuan Fann, Johan Rosell, Helena Fohlin, Robert A Smith and Stephen W Duffy
  Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 Decades
 
Altmetric usage: 18

  Radiology, 2011, 260(3), 658-663.
 Web of Science® Times Cited: 101

Gabriel Sandblom, Eberhard Varenhorst, Johan Rosell, Owe Lofman and Per Carlsson
  Letter: PROSTATE CANCER SCREENING Authors reply
  BMJ. British Medical Journal, 2011, 342, .

Gabriel Sandblom, Eberhard Varenhorst, Johan Rosell, Owe Lofman and Per Carlsson
  Randomised prostate cancer screening trial: 20 year follow-up
 
Altmetric usage: 11

  BRITISH MEDICAL JOURNAL, 2011, 342(d1539), .
   Fulltext  PDF  
 Web of Science® Times Cited: 45

Jasmine Loof, Johan Rosell, Charlotte Bratthall, Siv Doré, Hans Starkhammar, Hong Zhang and Xiao-Feng Sun
  Impact of PINCH expression on survival in colorectal cancer patients
  BMC CANCER, 2011, 11(103), .
   Fulltext  PDF  
 Web of Science® Times Cited: 1

Johan Rosell, Bo Nordenskjöld, N-O Bengtsson, T Fornander, T Hatschek, H Lindman, P-O Malmstrom, A Wallgren, Olle Stål and John Carstensen
  Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial
  British Journal of Cancer, 2011, 104(6), 899-902.
   Fulltext  PDF  
 Web of Science® Times Cited: 3

Staffan Jahnson, Ole Damm, Sverker Hellsten, Sten Holmang, Fredrik Liedberg, Borje Ljungberg, Per-Uno Malmstrom, Wiking Mansson, Johan Rosell and Hans Wijkstom
  Urinary diversion after cystectomy for bladder cancer: A population-based study in Sweden
  SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2010, 44(2), 69-75.
 Web of Science® Times Cited: 3

Katja Fall, Fredrik Strömberg, Johan Rosell and Eberhard Varenhorst
  Reliability of death certificates in prostate cancer patients
  Scandinavian Journal of Urology and Nephrology, 2008, 42(4), 352-357.
 Web of Science® Times Cited: 27

Jingfang Gao, Gunnar Arbman, L.. He, Zhiyong Zhang, Z. Zhao, Johan Rosell and Xiao-Feng Sun
  MANBA polymorphism was related to increased risk of colorectal cancer in Swedish but not in Chinese populations
  Acta Oncologica, 2008, 47(3), 372-378.

Georg Jancke, Ole Damm, Johan Rosell and Staffan Jahnson
  Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer
  Scandinavian Journal of Urology and Nephrology, 2008, 42(5), 417-421.
 Web of Science® Times Cited: 2

David Robinson, Gunnar Aus, Julia Bak, Tomasz Gorecki, Anders Herder, Johan Rosell and Eberhard Varenhorst
  Long-term follow-up of conservatively managed incidental carcinoma of the prostate A multivariate analysis of prognostic factors
  Scandinavian Journal of Urology and Nephrology, 2007, 41(2), 103-109.
 Web of Science® Times Cited: 13

Gunnar Aus, David Robinson, Johan Rosell, Gabriel Sandblom and Eberhard Varenhorst
  Survival in prostate carcinoma - Outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: Results from three counties in the population-based National Prostate Cancer Registry of Sweden
  Cancer, 2005, 103(5), 943- 951.
 Web of Science® Times Cited: 33

Bo Nordenskjöld, Johan Rosell, Lars-Erik Rutqvist, Per-Olof Malmström, Jonas Bergh, Nils-Olof Bengtsson, Thomas Hatschek, Arne Wallgren and John Carstensen
  Coronary heart disease mortality after 5 years of adjuvant tamoxifen therapy: Results from a randomized trial
  Journal of the National Cancer Institute, 2005, 97(21), 1609-1610.
 Web of Science® Times Cited: 40

Gabriel Sandblom, Eberhard Varenhorst, Owe Löfman, Johan Rosell and Per Carlsson
  Clinical consequences of screening for prostate cancer: 15 Years follow-up of a randomised controlled trial in Sweden
  European Urology, 2004, 46(6), 717-723.
 Web of Science® Times Cited: 52

Gunnar Aus, Kerstin Nordenskjöld, David Robinson, Johan Rosell and Eberhard Varenhorst
  Prognostic Factors and Survival in Node-Positive (N1) Prostate Cancer: A Prospective Study Based on Data from a Swedish Population-Based Cohort
  European Urology, 2003, 43(6), 627-631.
 Web of Science® Times Cited: 16

Ph.D. Theses

Johan Rosell
  Long-term effects of adjuvant tamoxifen treatment on cardiovascular disease and cancer
  2014.


  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.